Hero Patch is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value parenteral drugs.

The company’s patent-pending, porous microneedle technology provides the first practical and cost-effective platform to deliver clinically meaningful doses of macromolecules such as monoclonal antibodies.